To detect whether the TC-1-GLUC-LMP2 cells could survive and proliferate in vivo, we inoculated each mouse with 4 × 106 TC-1-GLUC-LMP2 cells, and the in vivo imaging system (IVIS) was used to observe tumor sizes in mice at three, seven and 14 days post-inoculation (Figure 6A–C). Here, PSMB9 is linked to neoplasm.